Bing Lu
Impact in
- Virology top 10%
- HIV Research and Treatment
-
- Drug Transport and Resistance Mechanisms
Papers in
-
- Epigenetics and DNA Methylation 5
- Histone Deacetylase Inhibitors Research 3
- RNA modifications and cancer 3
- Oncology 7
- Drug Transport and Resistance Mechanisms 3
- Co-authors
- Wei Zhao (11 shared papers)Warren Knudson (1 shared paper)John S. Coon (1 shared paper)Ronald S. Weinstein (1 shared paper)Jingxin Mo (2 shared papers)Xiaojia Huang (2 shared papers)Changye Zou (6 shared papers)Jincan He (3 shared papers)
- Journals
- Cell Death and Disease (3 papers)American Journal of Translational Research (2 papers)Advanced Science (2 papers)Frontiers in Pharmacology (2 papers)Journal of Pharmacology and Experimental Therapeutics (1 paper)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Bing Lu
33 papers receiving 762 citations
Peers
Comparison fields: 5 of 91
- Virology 58
- Oncology 201
- Cancer Research 92
- Biomaterials 78
- Pharmaceutical Science 36
Countries citing papers authored by Bing Lu
This map shows the geographic impact of Bing Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bing Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bing Lu more than expected).
Fields of papers citing papers by Bing Lu
This network shows the impact of papers produced by Bing Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bing Lu. The network helps show where Bing Lu may publish in the future.
Co-authors
The 25 scholars most cited alongside Bing Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Solutol HS 15, nontoxic polyoxyethylene esters of 12-hydroxystearic acid, reverses multidrug resistance. | 1991 | 110 |
| 2 | 2016 | 62 | |
| 3 | 2021 | 60 | |
| 4 | 2020 | 52 | |
| 5 | 2013 | 51 | |
| 6 | 2003 | 44 | |
| 7 | 2010 | 43 | |
| 8 | 2018 | 43 | |
| 9 | 2017 | 42 | |
| 10 | 2019 | 35 | |
| 11 | 2019 | 30 | |
| 12 | 2006 | 22 | |
| 13 | 2024 | 20 | |
| 14 | 2022 | 20 | |
| 15 | 2023 | 20 | |
| 16 | 2021 | 17 | |
| 17 | 2004 | 15 | |
| 18 | 2020 | 13 | |
| 19 | 2019 | 10 | |
| 20 | 2020 | 9 |
About Bing Lu
Bing Lu is a scholar working on Molecular Biology, Oncology, Pulmonary and Respiratory Medicine, Cancer Research and Infectious Diseases, having authored 34 papers that have together received 771 indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (5 papers), Histone Deacetylase Inhibitors Research (3 papers), RNA modifications and cancer (3 papers), Cancer-related molecular mechanisms research (3 papers), HIV/AIDS drug development and treatment (3 papers), Drug Transport and Resistance Mechanisms (3 papers), Cancer Research and Treatments (2 papers) and HIV/AIDS Research and Interventions (2 papers). The work is most often cited by research in Virology (58 citations), Oncology (201 citations), Cancer Research (92 citations), Biomaterials (78 citations) and Pharmaceutical Science (36 citations). Bing Lu has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Wei Zhao, Warren Knudson, John S. Coon, Ronald S. Weinstein, Jingxin Mo, Xiaojia Huang, Changye Zou, Jincan He, Yangyang He and Jiaming Yu. Their work appears in journals such as Cell Death and Disease, American Journal of Translational Research, Advanced Science, Frontiers in Pharmacology and Journal of Pharmacology and Experimental Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.